Monday, 8 January 2018

Global Radiation Therapy Market is expected to reach 8,680.6 million by 2024; Finds New Report

Radiation Therapy Global Market - Forecast To 2024

Radiation is one of the most common treatments for cancer and may be delivered by a machine outside the body (external-beam radiation therapy), or it may be delivered by a radioactive material placed in the body near cancer cells (internal radiation therapy/ brachytherapy), or by systemic radiation therapy which uses radioactive substances, such as radioactive iodine, that travel in the blood to kill cancer cells. About half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Radiation therapy is sometimes given with curative intent.

In such cases, radiation therapy may be used alone or in combination with surgery, chemotherapy, or both. It may also be given with palliative intent, which is not intended to cure; instead they relieve symptoms and reduce the suffering caused by cancer. For example, radiation given to the brain to shrink tumours formed from cancer cells that have spread to the brain from another part of the body.

Radiation therapy kills cancer cells either by damaging DNA directly or creates charged particles (free radicals) within the cells that can in turn damage the DNA, but does not travel throughout the body as chemotherapy treatment does. But, it can cause side effects, damaging healthy cells and tissues surrounding the tumour cells, in turn can also damage the surrounding organs and it may also leads to develop a secondary cancer as a result of exposure to radiation.

Today, major advances in radiation technology have made it more precise, leading to fewer side effects with the modern ways of giving radiation therapy and careful treatment planning aim to reduce the risk of these complications. The radiation therapy global market is expected to grow at mid single digit CAGR to reach 8,680.6 million by 2024.

The radiation therapy market is segmented based on their products, technology, end-users and geography. The radiation therapy market by products is segmented into external radiation therapy products, internal radiation therapy products and systemic radiation therapy products. The external radiation therapy products are further segmented into Linear accelerators (Linacs) and proton therapy systems. The internal radiation therapy product is further segmented into seeds, applicators & afterloaders, others (electronic brachytherapy & accessories) and systemic radiation therapy products are further segmented into alpha emitters and beta emitters.

Based on technologies, the radiation therapy market is segmented into external radiation therapy technologies, internal radiation therapies and systemic radiation therapy technologies. External radiation therapy technologies are further segmented into Stereotactic radio surgery (SRS), Stereotactic body radiation therapy (SBRT), Image-guided radiation therapy (IGRT), Intensity-modulated radiation therapy (IMRT); Volumetric modulated arc therapy (VMAT), Intensity-modulated proton therapy (IMPT) and others. Internal radiation therapy technology is further segmented into High dose rate brachytherapy, low dose rate brachytherapy and others. Based on applications, radiation therapy market is segmented into prostate cancer, breast cancer, gynaecological cancer, gastrointestinal cancer, lung cancer, brain cancer, head & neck cancer and others.

Based on end-users, radiation therapy market is segmented into hospitals, radiation therapy centres, ambulatory surgical centres and others. Further the radiation therapy global market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World. North America is further segmented into U.S. and Others. Europe is further segmented into Germany, Italy, France, and others. Asia-pacific region is further segmented into China, Japan, India and others and Rest of the world is further segmented into Brazil, Rest of Latin America and Middle East & Others.

Spanning over 398 pages Radiation Therapy Global Market - Forecast To 2024” report covers Executive Summary, Introduction, Market Analysis, Radiation Therapy Global Market, By Product Type, Radiation Therapy Global Market, By Technology, Radiation Therapy Global Market By Applications, Radiation Therapy Global Market, By End-Users, Regional Analysis, Competitive Landscape, Major Companies. This Report Covered Companies Few Are - Anazao Health Corporation, Antisoma Plc Ltd, Bionucleonics Inc., Cianna Medical, Core Oncology Inc., Bayer Healthcare Pharmaceuticals Llc, Bionix, Brain Lab, Inc., Bxtaccelyon Limited, Carl Zeiss Meditech, Inc., C.R. Bard Inc, Cirs, Civco Radiation Therapy, C-Rad Ab, Dosisoft, Eckert & Ziegler Bebig, Elekta Ab, Filtrine, Ge Healthcare, Hamming Hitachi Medical Corporation, Hologic Inc, Huiheng Medical.

Please visit this link for more details: http://mrr.cm/UpP

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

Thursday, 4 January 2018

US Market Report for Transcatheter Heart Valve Replacement Machines 2018 Market Report; Launched via MarketResearchReports.com

US Market Report for Transcatheter Heart Valve Replacement Machines 2018

The nomenclature for such devices includes transcatheter heart valve replacement (THVR) and percutaneous heart valve replacement. In this instance, ‘percutaneous’ is used interchangeably with ‘transcatheter’. For the sake of this report, these devices will be referred to as transcatheter heart valve replacement devices. The industry standard is to define these products further by denoting the specific heart valve for which the device is indicated. Examples of this would be transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) devices and transcatheter pulmonary valve replacement (TPVR) devices.

In a transcatheter heart valve replacement procedure, a collapsible replacement valve is delivered to the damaged valve via a balloon catheter. The balloon catheter then inflates to expand the replacement within the old valve, pushing the old valve leaflets out of the way and allowing the replacement valve to regulate blood flow. The balloon catheter is then deflated and removed.

The primary method for treating heart valve conditions is through open surgery to place a replacement valve. Biological tissue valves can be allografts (provided by deceased donors), xenografts (bovine or porcine valves) or autografts (using the patient’s own pulmonary valve, which in turn, needs to be replaced). Tissue valves have been gaining popularity over the alternative mechanical valves because tissue valves are much more biocompatible and do not require lifelong treatment with anti-coagulant medication.

However, mechanical valves are more durable and are designed to last for 20-30 years, whereas bioprosthetic valves last 10-15 years. Some patients with heart valve problems are poor candidates for valve replacement surgery because they may be too ill to undergo such an invasive procedure. Therefore, there is a great deal of interest in the development of transcatheter heart valve replacement (THVR) devices.

Spanning over 381 pages US Market Report for Transcatheter Heart Valve Replacement Machines 2018 - MedCore” report covers Executive Summary, U.S. Cardiac Surgery And Heart Valve Device Market Overview, Competitive Analysis, Market Trends, Market Developments, Research Methodology, Disease Overview, Product Portfolio, Transcatheter Heart Valve Replacement Device Market, Appendix. This report Covered Companies - Edwards Lifesciences, St. Jude Medical, Medtronic, Maquet, Abiomed, HeartWare Inc., Sorin Group, Terumo, Abbott Laboratories, Teleflex Medical, Cardiac Assist, AtriCure, W.L. Gore, SynCardia, Boston Scientific, Cryolife, Others include: Berlin Heart, Cardica, Chase Medical, Genesee Biomedical, Karl Storz, LifeNet Health, Microline Surgical, Novadaq, On-X, Saphena Medical, SentreHeart, Vitalitec, etc.

Please visit this link for more details: http://mrr.cm/UGw

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

US Market Report for Remote Hemodynamic Monitoring Systems 2018 Market Report; Launched via MarketResearchReports.com

US Market Report for Remote Hemodynamic Monitoring Systems 2018

Heart failure occurs when the heart is unable to pump sufficiently to maintain blood flow to meet the body’s needs. Changes in the pressure of blood through the pulmonary artery can be an indicator of heart failure or worsening heart failure. Following changes in blood pressure, heart failure will cause shortness of breath and weight gain.

Heart failure is diagnosed by history of symptoms and a physical examination with confirmation echocardiology. Heart failure afflicts 2% of the adult population in developed nations, which increases to 6 to 10% for those above the age of 65. The highest risk of death is generally right after diagnosis, at around 35%.

Remote hemodynamic monitoring devices are implanted into the patient to monitor the blood pressure in the pulmonary artery. The device takes measurements from inside the body and transmits the data to a secure website for clinicians to review. The clinicians are then able to preemptively able to detect heart failure and treat them before symptoms arise.

Spanning over 377 pages US Market Report for Remote Hemodynamic Monitoring Systems 2018 - MedCore” report covers Executive Summary, U.S. Cardiac Surgery And Heart Valve Device Market Overview, Competitive Analysis, Market Trends, Research Methodology, Disease Overview, Product Portfolio, Remote Hemodynamic Monitoring System Market, Appendix. This report Covered Companies - Edwards Lifesciences, St. Jude Medical, Medtronic, Maquet, Abiomed, HeartWare Inc., Sorin Group, Terumo, Abbott Laboratories, Teleflex Medical, Cardiac Assist, AtriCure, W.L. Gore, SynCardia, Boston Scientific, Cryolife, Others include: Berlin Heart, Cardica, Chase Medical, Genesee Biomedical, Karl Storz, LifeNet Health, Microline Surgical, Novadaq, On-X, Saphena Medical, SentreHeart, Vitalitec, etc.

Please visit this link for more details: http://mrr.cm/Upt

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

US Market Report for Tissue Heart Valves 2018 Market Report; Launched via MarketResearchReports.com

US Market Report for Tissue Heart Valves 2018

The vast majority of commercially available tissue valves are xenograft valves derived from animals. Usually, the valves are porcine, meaning from a pig, or bovine, meaning from a cow. The porcine heart is most similar to the human heart and therefore represents the best anatomical fit for replacement. The tissue of the pericardial sac is particularly well suited for a valve leaflet due to its extremely durable physical properties. Before implantation, the tissue undergoes multiple chemical treatments to make it suitable for replacement in the human heart.

The tissue is sterilized so that the biological markers are removed, thereby eliminating a response from the host's immune system. The primary advantage of tissue over mechanical valves is that tissue valves are much more biocompatible and thus a patient who receives a tissue valve does not require life-long anti-coagulation therapy. However, a disadvantage of tissue valves is that they are not as durable and typically last between 15 and 20 years before requiring replacement.

Nevertheless, advances in polymer coatings have made tissue valves more durable than ever before. Furthermore, several aortic tissue valve replacement devices under development that are currently undergoing clinical trials in the U.S. or awaiting FDA approval may be implanted percutaneously.

Tissue valves, which are also known as bioprosthetic valves, are harvested from either human donors or animal tissue. Human tissue valves can either be obtained from donor cadavers in allograft procedures, or from one’s own body in an autograft procedure. Allograft valves may be acquired from deceased family members or anonymous donors.

Autograft valves may be obtained through a Ross procedure, whereby part of the pulmonary valve is grafted and harvested into the aortic position. Whether autograft or allograft, human donor valves involve complicated extraction and insertion procedures. Human tissue valves are in limited supply and typically do not function drastically better than xenograft valves.

Spanning over 395 pages US Market Report for Tissue Heart Valves 2018 - MedCore” report covers Executive Summary, U.S. Cardiac Surgery And Heart Valve Device Market Overview, Competitive Analysis, Market Trends, Market Developments, Research Methodology, Disease Overview, Product Portfolio, Tissue Heart Valve Market, Appendix. This report Covered Companies - Edwards Lifesciences, St. Jude Medical, Medtronic, Maquet, Abiomed, HeartWare Inc., Sorin Group, Terumo, Abbott Laboratories, Teleflex Medical, Cardiac Assist, AtriCure, W.L. Gore, SynCardia, Boston Scientific, Cryolife, Others include: Berlin Heart, Cardica, Chase Medical, Genesee Biomedical, Karl Storz, LifeNet Health, Microline Surgical, Novadaq, On-X, Saphena Medical, SentreHeart, Vitalitec, etc.

Please visit this link for more details: http://mrr.cm/UGS

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

US Market Report for Transmyocardial Revascularization Devices 2018 Market Report; Launched via MarketResearchReports.com

US Market Report for Transmyocardial Revascularization Devices 2018

Angina is the medical term used for describing the chest pain or discomfort that an individual can experience when the heart does not receive an adequate supply of oxygen-rich blood. This can occur when the arteries supplying blood flow to the heart muscle become partially blocked or narrowed by the accumulation of fatty deposits known as plaque. This condition, where plaque progressively builds up in the interior walls of the arteries, resulting in reduced blood flow to the myocardium, ischemia and angina, is known as coronary atherosclerosis.

The primary therapeutic options for treatment of coronary artery disease are drug therapy, percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). However, many patients with severe angina experience inadequate response to pharmacological approaches and require surgical treatment such as PCI with or without stenting, or CABG.

Many patients with chronic, severe angina are not candidates for PCI or CABG because of a variety of reasons including failed prior procedures, diffuse coronary artery disease, distal stenosis or extremely small coronary arteries. These patients represent the primary target population for treatment with TMR.

Transmyocardial revascularization (TMR) is a surgically performed laser-based heart treatment procedure in which transmural channels are made in the heart muscle. Many scientific experts believe that these procedures encourage new vessel formation, also known as angiogenesis. TMR therapy is approved for patients suffering from chronic or severe angina. The American Heart Association (AHA) estimates that approximately 9.8 million Americans experience angina symptoms.

Spanning over 390 pages US Market Report for Transmyocardial Revascularization Devices 2018 - MedCore” report covers Executive Summary, U.S. Cardiac Surgery And Heart Valve Device Market Overview, Competitive Analysis, Market Trends, Market Developments, Research Methodology, Disease Overview, Product Portfolio, Transmyocardial Revascularization Device Market, Appendix. This report Covered Companies - Edwards Lifesciences, St. Jude Medical, Medtronic, Maquet, Abiomed, HeartWare Inc., Sorin Group, Terumo, Abbott Laboratories, Teleflex Medical, Cardiac Assist, AtriCure, W.L. Gore, SynCardia, Boston Scientific, Cryolife, Others include: Berlin Heart, Cardica, Chase Medical, Genesee Biomedical, Karl Storz, LifeNet Health, Microline Surgical, Novadaq, On-X, Saphena Medical, SentreHeart, Vitalitec, etc.

Please visit this link for more details: http://mrr.cm/UGo

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

Global Biological Safety Testing Market to grow at a CAGR of 11.12% during the period 2017 - 2021; Finds New Report

Global Biological Safety Testing Market 2017 - 2021

Report forecast the global biological safety testing market to grow at a CAGR of 11.12% during the period 2017-2021.

Biological safety ensures the biological integrity of products that are meant for consumption. Biological safety testing examines facilities and tests them for various types of contaminations. Several instruments, reagents, and kits are used for biological safety testing. Due to the increasing number of product recalls, which have caused significant losses for pharmaceutical companies, the focus on biological safety testing is increasing. Pharmaceutical and biotechnology companies are making significant investments in research and development (R&D) to develop safe products.

The report covers the present scenario and the growth prospects of the global biological safety testing market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA

According to the report, one of the major drivers for this market is Growing biotechnology and pharmaceutical industries. Biological safety testing is essential to ensure the safety of finished products in the biotechnology and pharmaceutical industries. Regulatory compliance and ensuring the production of products that are free from contaminations are essential for the success of pharmaceutical and biotechnology companies. Regulatory organizations require pharmaceutical products to comply with standard regulatory procedures. Due to the growing number of biopharmaceuticals, the demand for biological safety testing will increase during the forecast period. Therefore, the growth of the biotechnology and pharmaceutical industries will drive the growth of the global biological safety testing market.

Further, the report states that one of the major factors hindering the growth of this market is Lack of trained professionals. Biological safety testing requires efficient handling and compliance with regulatory procedures and good manufacturing practices. Due to the growing prevalence of chronic diseases, laboratories are required to develop new drugs quickly, which can affect adherence with regulatory procedures. If the quality of new drugs is not adequate, biopharmaceutical companies can incur significant losses. In April 2017, in India, the Central Drugs Standard Control Organization (CDSO) listed 60 drugs as unsafe for use because they were adulterated, spurious, misbranded, or not of standard quality.

Global Biological Safety Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global biological safety testing market: Merck, Lonza, SGS, and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: Air Science, Avance Biosciences, BSL Bioservice, Charles River Laboratories, Esco Micro, Nordic Scientific & Natural Solutions, NuAire, and WuXi Biologics.

Market driver
  • Growing biotechnology and pharmaceutical industries
  • For a full, detailed list, view our report

Market challenge
  • Lack of trained professionals
  • For a full, detailed list, view our report

Market trend
  • International conferences promoting best practices of biosafety
  • For a full, detailed list, view our report

Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

Spanning over 74 pages Global Biological Safety Testing Market 2017 - 2021” report covers Executive summary, Introduction, Scope of the report, Research Methodology, Market landscape, Segmentation by offering, Segmentation by geography, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Please visit this link for more details: http://mrr.cm/UNo

For related reports please visit: Biological Safety Testing Market Research Reports

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

China Medical Trolleys Market Research Report Forecast 2017 to 2022; New Report Launched

China Medical Trolleys Market Research Report Forecast 2017 to 2022

The China Medical Trolleys Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Medical Trolleys industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Medical Trolleys market study provides comprehensive data which enhances the understanding, scope and application of this report. (This report is also available in Chinese Language)

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
  • BDI
  • lotustone
  • ICW
  • Alphason
  • Barkan

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Spanning over 101 pages China Medical Trolleys Market Research Report Forecast 2017 to 2022” report covers Medical Trolleys Market Overview, China Economic Impact on Medical Trolleys Industry, China Medical Trolleys Market Competition by Manufacturers, China Medical Trolleys Capacity, Production, Revenue, Consumption, Export and Import (2012-2017), China Medical Trolleys Production, Revenue (Value), Price Trend by Type, China Medical Trolleys Market Analysis by Application, China Medical Trolleys Manufacturers Analysis, Medical Trolleys Manufacturing Cost Analysis, Industrial Chain, Sourcing Strategy and Downstream Buyers, Marketing Strategy Analysis, Distributors/Traders, Market Effect Factors Analysis, China Medical Trolleys Market Forecast (2017-2022), Appendix. This report Covered Companies - BDI lotustone ICW Alphason Barkan.

For more information Visit at: http://mrr.cm/UNP

For related Geographical reports please visit: Medical Trolley Market Research Reports

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare